This company

Venture-backed company · Stage unknown· CA
Rounds on record
4
Latest round
Aug 1, 2012
Form D equity offering
Latest round size
$2.0M
Form D industry: Pharmaceuticals
More
As of · the latest observation of this company; each round carries its own date

The company's name, 1 additional officer or director, 8 additional investors

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

What matters now

  1. 2 investors
    named

    2 investors on record.

    The investors already on the cap table shape who leads the next round.

    Factfunding announcements, portfolio pages and Form DFor Investors, foundersInvestors →
  2. 4 directors
    board

    4 directors on record from Form D filings and board-seat attributions.

    The board is who decides on the next round and on a sale.

    FactSEC Form D related personsFor Investors, acquirersPeople →
Drawing the relationship network…

Facts

Year of incorporation
2007sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
4
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
2

Financing history

4 rounds
  1. Aug 1, 2012
    Form D equity offering · $2.0M (form d sold) · 6 investors
    Scale Venture Partners via Louis Craig BockDomain Associates, LLC via KIM Puloma Kamdar
    Fact Form D
  2. Mar 29, 2012
    Form D equity offering · $1.2M (form d sold) · 7 investors
    Scale Venture Partners via Louis Craig BockDomain Associates, LLC via KIM Puloma Kamdar
    Fact Form D
  3. Oct 7, 2011
    Form D equity offering · $999,994 (form d sold) · 7 investors
    Scale Venture Partners via Louis Craig BockDomain Associates, LLC via KIM Puloma Kamdar
    Fact Form D
  4. Jan 15, 2008
    Form D equity offering · $37.2M (form d sold) · 7 investors
    Fact Form D

Who would invest

2 investors on record, then the firms most like them

Already invested

2 investors on record

Strong comparable investors

0 firms

Firms that backed two or more of the companies this company's own investors also back.

No firm backed two or more of the companies this company's investors back, so there is no comparable investor on record yet.

Broader fit

1 firm

Firms that co-invest repeatedly with this company's investors and dated a new company in the last 12 months.

  1. Sequoia Capital
    • Co-invested 5 times with 1 of this company's investors
    • Has joined rounds of $1M to $5M (1 on record)
    • Invests in Life sciences
    • 12 new companies dated in the last 12 months, latest Sep 11, 2026
    • Led 25% of 12 rounds whose lead is known

Ownership and outcomes

none on record
Outcome stated by investors

No firm portfolio page lists this company, so no outcome is stated.

No later owner or exit on record: no private equity sponsor position and no acquisition, listing or IPO report names this company.

Credit relationships

none on record
No lender position matched to this company.

People

2 officers, 4 directors

Timeline

0 events
No dated event on record.

Evidence

5 observations
Every observation on this company
  • Form D industry group: Pharmaceuticals Aug 2, 2012 Fact Form D
  • Revenue range (Form D): Decline to Disclose Aug 2, 2012 Fact Form D
  • Jurisdiction: Delaware Aug 2, 2012 Fact Form D
  • Office address: Aug 2, 2012 Fact Form D
  • Year of incorporation: 2007 Aug 2, 2012 Fact Form D